EUVIMED · CrossrefZeitschrift
Neurobehavioral HIV Medicine
ISSN 1179-1497 · Informa UK Limited
Neueste Artikel
Evidence-based perspectives on the implementation of screening for neurocognitive impairment in HIV
HIV-associated progressive multifocal leukoencephalopathy: current perspectives
Anti-HIV-1 drug toxicity and management strategies
Exploration of a genomic expression and pathway analysis approach to neurocognitive performance: preliminary findings
Rates of mood and anxiety disorders and contributors to continued heroin use in methadone maintenance patients: A comparison by HIV status
Relationships between the use of second-generation antipsychotics and changes in total cholesterol levels in children and adolescents perinatally infected with HIV
Effect of older age at initiation of antiretroviral therapy on patient retention in an urban ART program in Uganda
Depression, alcohol abuse, and disclosure of HIV serostatus among rural HIV-positive individuals in western Uganda
Gene expression for HIV-associated dementia and HIV encephalitis in microdissected neurons 1: preliminary analysis
Cognitive function in treated HIV patients
Substance abuse, hepatitis C, and aging in HIV: common cofactors that contribute to neurobehavioral disturbances
Immune activation and neuropsychiatric symptoms in human immunodeficiency virus type 1 infection
Stress management interventions for HIV-infected individuals: review of recent intervention approaches and directions for future research
Expression of mannose binding lectin in HIV-1-infected brain: implications for HIV-related neuronal damage and neuroAIDS
A comparison of screening batteries in the detection of neurocognitive impairment in HIV-infected Spanish speakers
Emerging viral and bacterial infections of the central nervous system
The neuro-ophthalmology of HIV-AIDS review of Neurobehavioral HIV Medicine
Prognosis and management of cryptococcal meningitis in patients with human immunodeficiency virus infection
Neuropsychiatric effects of tenofovir in comparison with other antiretroviral drugs
HIV treatment: mechanisms of neurotoxicity and implications for targeted therapy
Cognitive reserve masks neurobehavioral expression of human immunodeficiency virus-associated neurological disorder in older patients
Management issues in HIV-associated neurocognitive disorders
Baseline medication adherence and response to an electronically delivered health literacy intervention targeting adherence
Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity
CCL3 genotype and current depression increase risk of HIV-associated dementia
Alcohol use and gender effects on HIV risk behaviors in cocaine-using methadone patients
Neurodevelopmental delay in pediatric HIV/AIDS: current perspectives
Prevalence, impact, and management of depression and anxiety in patients with HIV: a review
Gender and racial differences in risk factors for sexually transmitted diseases among justice-involved youth
A guide to interpretation of neuroimmunological biomarkers in the combined antiretroviral therapy-era of HIV central nervous system disease
EUVIMED